Good summary Lightforce !, some additions to consider,
4 new patents achieved recently boosting the IP position even further, plus 11 completed clinical studies within various markets which can only consolidate the perception of the health benefits of a2 products.
Market disrupting, solid IP, high moat, high gross margins, strong forward growth.
And, substantially undervalued according to many analysts who are awaiting further risk to fall away, investors should be cognisant of those risks also though.
A2M Price at posting:
$1.01 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)